131.83
前日終値:
$125.61
開ける:
$131.375
24時間の取引高:
114.72K
Relative Volume:
0.22
時価総額:
$8.40B
収益:
$3.78B
当期純損益:
$392.50M
株価収益率:
22.41
EPS:
5.8837
ネットキャッシュフロー:
$294.56M
1週間 パフォーマンス:
+3.96%
1か月 パフォーマンス:
-0.23%
6か月 パフォーマンス:
+0.13%
1年 パフォーマンス:
-1.41%
Aptargroup Inc Stock (ATR) Company Profile
Compare ATR vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ATR
Aptargroup Inc
|
131.77 | 8.01B | 3.78B | 392.50M | 294.56M | 5.8837 |
|
ISRG
Intuitive Surgical Inc
|
468.21 | 160.87B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
157.03 | 44.08B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.64 | 36.40B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
44.30 | 35.00B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
233.06 | 32.93B | 5.40B | 1.49B | 1.78B | 10.12 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-20 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-06 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-11-03 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-09-04 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-01-07 | 開始されました | Raymond James | Outperform |
| 2025-01-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2024-04-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | 開始されました | Seaport Global Securities | Neutral |
| 2020-04-27 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | 開始されました | Morgan Stanley | Overweight |
| 2019-04-05 | 繰り返されました | BofA/Merrill | Underperform |
| 2019-02-27 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | 開始されました | Jefferies | Hold |
| 2016-12-07 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | 開始されました | Jefferies | Hold |
| 2016-01-05 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | アップグレード | Deutsche Bank | Hold → Buy |
| 2015-09-15 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | 繰り返されました | Deutsche Bank | Hold |
| 2013-01-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | ダウングレード | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | 開始されました | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | アップグレード | KeyBanc Capital Mkts | Hold → Buy |
すべてを表示
Aptargroup Inc (ATR) 最新ニュース
Rally Mode: Is AptarGroup Inc a stock for growth or value investorsTrade Exit Report & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
BofA Securities Adjusts Price Target on AptarGroup to $145 From $147, Maintains Neutral Rating - marketscreener.com
Aptargroup Inc at Raymond James Institutional Investors Conference Transcript - GuruFocus
JB Capital LLC Acquires New Position in AptarGroup, Inc. $ATR - MarketBeat
SG Americas Securities LLC Increases Stock Holdings in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
AptarGroup, Inc. (ATR) Stock forecasts - Yahoo Finance UK
How Investors May Respond To AptarGroup (ATR) Powering ENA’s Phase II Intranasal Antiviral Study - simplywall.st
Assenagon Asset Management S.A. Has $1.25 Million Stock Position in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. (NYSE:ATR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
AptarGroup hires new CEO - MSN
Merger Talk: Is AptarGroup Inc stock undervalued right now2026 Major Catalysts & Intraday High Probability Setup Alerts - baoquankhu1.vn
AptarGroup Inc Stock: Packaging Leader Positions for Sustainable Pharma and Beauty Growth Amid Secto - AD HOC NEWS
Breakouts Watch: Is AptarGroup Inc a stock for growth or value investors2026 PreEarnings & Accurate Buy Signal Notifications - baoquankhu1.vn
AptarGroup Inc (STU:AGT) Bonds - GuruFocus
AptarGroup (NYSE: ATR) 2026 proxy details CEO change, pay and 2025 results - stocktitan.net
Tudor Investment Corp ET AL Sells 33,999 Shares of AptarGroup, Inc. $ATR - marketbeat.com
Global Pump and Dispenser Market to Reach USD 84.6 Billion by 2036 Led by North America and AptarGroup Inc. Innovation - National Today
Global Pump and Dispenser Market to Reach USD 84.6 Billion by 2036 Led by North America and AptarGroup Inc. - EIN News
Dropper Market Set to Boom Rapidly by 2033 | AptarGroup Inc. • Berry Global Inc. • Silgan Holdings Inc - openPR.com
Vanguard reports 0 shares of AptarGroup (NYSE: ATR) after internal realignment - Stock Titan
Nordea Investment Management AB Invests $7.31 Million in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup Inc stock faces CEO transition in 2026 amid analyst upgrades and pharma delivery wins - AD HOC NEWS
Aptar to gain new CEO later this year - Plastics News
Pharmaceutical Unit Dose Packaging Market Is Going to Boom | AptarGroup Inc. • Omnicell Inc. • Becton - openPR.com
AptarGroup’s Nasal Devices Gain Ground In Respiratory Trials And Leadership Shift - simplywall.st
AptarGroup (ATR) Segment President Hedi Tlili receives 10,803-share stock grant - Stock Titan
AptarGroup (ATR) CFO Vanessa Kanu receives 10,960-share stock grant - Stock Titan
ATR SEC FilingsAptargroup 10-K, 10-Q, 8-K Forms - Stock Titan
AptarGroup (ATR) Receives Analyst Upgrade with Increased Price T - GuruFocus
AptarGroup (NYSE:ATR) Stock Rating Upgraded by Wells Fargo & Company - MarketBeat
Wells Fargo Upgrades AptarGroup to Overweight From Equalweight, Adjusts PT to $144 From $133 - marketscreener.com
CEO transition puts pharma business in the driver’s seat at Aptar - Crain's Chicago Business
AptarGroup (NYSE: ATR) awards options and stock to executive - Stock Titan
AptarGroup (ATR) segment president receives option and stock grants - Stock Titan
AptarGroup (ATR) CFO granted 16,858 options and 4,332 shares - Stock Titan
Aptar's Unidose Powder Nasal Delivery System Used in ENA Respira - GuruFocus
AptarGroup (ATR) Partners in Clinical Study for Nasal Spray Syst - GuruFocus
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray - Aptar
AptarGroup Hires New CEO - Sahm
JPMorgan Chase & Co. Grows Holdings in AptarGroup, Inc. $ATR - MarketBeat
First Financial Bank Trust Division Has $248,000 Position in AptarGroup, Inc. $ATR - marketbeat.com
AptarGroup (NYSE: ATR) executive uses 273 shares to cover taxes - Stock Titan
[Form 4] APTARGROUP, INC. Insider Tradin... - Stock Titan
AptarGroup (NYSE: ATR) CFO reports routine 368-share tax withholding - Stock Titan
AptarGroup (NYSE: ATR) exec has shares withheld for taxes - stocktitan.net
AptarGroup (NYSE: ATR) CLO uses 37 shares for tax withholding - Stock Titan
[Form 4] APTARGROUP, INC. Insider Trading Activity - Stock Titan
AptarGroup (NYSE: ATR) CEO reports 1,772-share tax withholding transaction - Stock Titan
AptarGroup Appoints Gael Touya as President & CEO Effective September 1, 2026 - Minichart
Aptar appoints Gael Touya as CEO - MSN
Aptargroup Inc (ATR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):